AARTIDRUGSNSEAARTI DRUGS LTD.· Pharmaceuticals & BiotechnologyCriticalNegative
Announced Wed, 30 Sept, 2026 · 19:49 IST

Chairman, MD and CEO retires; CFO promoted to Managing Director

Ceo ResignedCfo ResignedPromoter Family Board EntryManagement Changes View source PDFExplain this filing

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.0%Reaction day
₹432.00
prior close
₹431.05
announcement price
After-mkt
timing
Nifty Microcap 250market-1.3%-1.7% vs market
Pharmaceuticals peers, median of 173sector-0.8%-2.2% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 2.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.1
10m
-1.5
15m
-0.5
30m
-1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.0-1.3-1.7-0.8-2.2
Next day
-4.1-1.3-2.8-1.2-2.8
2d
-0.8+0.0-0.8-0.4-0.4
3d
-3.3-0.2-3.1-0.1-3.2
4d
-3.2-3.0-0.3-3.0-0.2
5d
-4.5-2.7-1.8-3.1-1.4
1w
-5.2-1.7-3.4-3.0-2.1
15d
-12.0-8.9-3.2-6.9-5.1
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Prakash M. Patil retired early as Chairman, MD and CEO of Aarti Drugs, effective September 30, 2026. Adhish P. Patil, the previous CFO, has been promoted to Managing Director from October 1, 2026, after shareholder approval at the AGM on September 26. He relinquished the CFO role and the company will appoint a new CFO shortly. The transition appears orderly within the Patil family, with Prakash's term originally set to expire on May 31, 2027.

Likely market impact

Family succession: Prakash M. Patil retires as Chairman, MD and CEO; Adhish Patil promoted to MD from CFO role. CEO and CFO posts to be filled.